1. Home
  2. HWBK vs FENC Comparison

HWBK vs FENC Comparison

Compare HWBK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

N/A

Current Price

$33.68

Market Cap

233.3M

Sector

Finance

ML Signal

N/A

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

HOLD

Current Price

$5.86

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
FENC
Founded
1865
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3M
266.4M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
HWBK
FENC
Price
$33.68
$5.86
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
6.1K
206.5K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
2.40%
N/A
EPS Growth
31.42
N/A
EPS
3.43
N/A
Revenue
N/A
$44,642,000.00
Revenue This Year
N/A
$69.68
Revenue Next Year
N/A
$37.30
P/E Ratio
$10.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$4.98
52 Week High
$36.25
$9.92

Technical Indicators

Market Signals
Indicator
HWBK
FENC
Relative Strength Index (RSI) 55.41 34.75
Support Level $33.28 $5.65
Resistance Level $35.88 $9.16
Average True Range (ATR) 1.07 0.44
MACD 0.18 0.00
Stochastic Oscillator 83.13 10.70

Price Performance

Historical Comparison
HWBK
FENC

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: